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Abstract
Background:  Adamantinoma  is  a  rare  lesion  of  low-grade  malignancy,  and  represents  1%  of
malignant  bone  tumours  of  bones,  and  is  mainly  located  in  two  regions  of  the  body,  jaw
(ameloblastoma),  and  lower  extremities.  The  treatment  of  choice  is  surgery  due  to  it  being
a radio-  and  chemotherapy-resistant  neoplasia.
Clinical  case:  A  39-year-old  male  with  a  history  of  neonatal  hydrocephalus  with  moderate  psy-
chomotor retardation.  He  began  with  pain  in  the  posterior  region  of  the  left  thigh  for  one  year
before admission,  which  was  managed  as  posterior  radicular  syndrome.  He  had  sudden  intense
pain on  walking  that  led  him  to  fall  over.  In  the  examination,  left  pelvic  limb  with  deformity  in
the distal  third  with  increase  in  volume  in  the  thigh,  with  pain  to  palpation,  and  presence  of
crackles in  the  distal  third  of  the  femur  were  observed.  A  biopsy  of  the  thigh  was  performed,
with subsequent  local  wide  excision  +  replacement  of  bone  with  cadaver  bone  and  a  central
medullary nail.  The  ﬁnal  diagnosis  was  adamantinoma  of  femur. Please cite this article as: Carrera-Muin˜os A, Díaz-González C, Monges-Jones JE, Carballo-Zarate A, Colin-Carrasco J. Tratamiento de
adamantinoma de fémur con preservación de extremidad. Reporte de un caso y revisión de la literatura. Cir Cir. 2015;83:249--54.
∗ Corresponding author at: Ejército Nacional 613, sala 15-16D, Col.: Granada, Del.: Miguel Hidalgo, C.P. 11520, México D.F., México.
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Conclusion:  Adamantinomas  are  rare  tumours.  It  is  important  to  recognise  this  type  of  tumour
from the  beginning,  since  its  prognosis  is  excellent  in  initial  stages.  It  is  important  to  have  free
margins as  survival  is  very  high.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
PALABRAS  CLAVE
Tumor  óseo;
Adamantinoma;
Conservación  de
extremidad
Tratamiento  de  adamantinoma  de  fémur  con  preservación  de  extremidad.  Reporte  de
un  caso  y  revisión  de  la  literatura
Resumen
Antecedentes:  El  adamantinoma  es  una  rara  lesión  de  bajo  grado  de  malignidad,  representa
<1% de  los  tumores  malignos  de  huesos,  se  localiza  principalmente  en  2  regiones  del  cuerpo,
la mandíbula  (ameloblastoma)  y  las  extremidades  inferiores.  El  tratamiento  de  elección  es  la
cirugía ya  que  se  trata  de  una  neoplasia  resistente  a  la  radioterapia  y  quimioterapia.
Caso clínico:  Paciente  masculino  de  39  an˜os  de  edad  con  antecedente  de  hidrocefalia  neonatal
con retraso  psicomotor  moderado.  Un  an˜o  previo  a  su  ingreso  comenzó  con  dolor  en  región
posterior del  muslo  izquierdo,  el  cual  se  manejó  como  síndrome  radicular;  posteriormente
presentó  dolor  súbito  intenso  a  la  deambulación,  por  lo  que  tuvo  caída  de  su  propia  altura.  A  la
exploración  de  miembro  pélvico  izquierdo  con  deformidad  en  el  tercio  distal  con  aumento  de
volumen en  el  muslo,  dolor  a  la  palpación  y  presencia  de  crepitación  en  tercio  distal  de  fémur.
Se le  realizó  biopsia  en  muslo,  posterior  escisión  local  amplia  +  colocación  de  hueso  de  cadáver
con clavo  centromedular  con  reporte  deﬁnitivo  de  adamantinoma  de  fémur.
Conclusión:  Los  adamantinomas  son  tumores  raros  y  es  importante  reconocer  este  tipo  de
tumores desde  un  inicio,  ya  que  su  pronóstico  es  excelente  en  etapas  iniciales.  Es  importante
tener bordes  libres  ya  que  la  supervivencia  es  muy  alta.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Mackground
rimary  bone  tumours  are  neoplasias  that  represent  less
han  0.2%  of  all  malignant  tumours.  The  most  common  ones
re  osteosarcoma  (35%),  chondrosarcoma  (30%)  and  Ewing’s
arcoma  (16%);  adamantinoma  only  occurs  in  <1%.1 The  ﬁrst
ase  reported  is  attributed  to  Maier  in  the  year  1900.2 In
913,  Fisher  reported  the  ﬁrst  tibia  adamantinoma.3
The  origin  of  this  disease  is  currently  unknown.  However,
here  are  various  hypotheses.  Fisher  proposed  a  congeni-
al  implantation  of  epithelial  cells3;  Ryrie,4 Dockerty  and
eyerding5 are  in  favour  of  a  traumatic  implantation;  Led-
rer  and  Sinclair,6 Naji  et  al.7 propose  a  synovial  origin.
urrently,  the  theory  that  states  that  this  disease  has  an
pithelial  origin  is  a  subject  of  debate;  during  the  devel-
pment  of  the  embryo  the  basal  epithelium  shifts,  which
upports  this  since  the  most  frequent  place  is  the  anterior
art  of  the  tibia  where  there  is  proximity  to  the  skin.8 Among
he  revised  cases  by  Moon  and  Mori,  60%  of  200  cases  had  a
istory  of  trauma  in  the  tumour  area.9
linical case 39-year-old  male  patient  with  relevant  medical  history;
is  mother  died  of  breast  cancer.  He  suffered  from  neona-
al  hydrocephalia  with  moderate  psychomotor  retardation.
t
m
n
ohe  onset  of  the  disease  was  a  year  before  admission,  with
ain  in  the  posterior  part  of  his  left  thigh.  It  was  treated
y  multiple  doctors  as  radicular  syndrome  with  mild  pain
mprovement.  He  attended  the  casualty  department  due  to
udden  intense  pain  during  ambulation  with  no  lesion  mech-
nism,  causing  him  to  fall  from  standing  height  with  limb
eformity  and  reduced  mobility.  During  physical  examina-
ion,  a  deformity  in  his  left  pelvic  limb  could  be  observed,
ocated  at  the  distal  third  of  his  thigh.  There  was  volume
ugmentation,  pain  on  palpation  on  femoral  diaphysis  and
repitation  on  the  distal  third  of  the  femur.  Sensitivity  was
onserved  and  pulses  present  were  not  compromised.  Chest
-ray  showed  no  alterations.  Anteroposterior  and  lateral
emur  X-rays:  with  cross-sectional  breaks  in  continuity  at
he  distal  third  of  the  femur,  in  pathological  area,  due  to  the
resence  of  a  radiolucent,  medullar,  expansive,  monostotic
esion  of  70  mm  ×  45  mm.  There  was  periosteal  reaction  and
he  transition  area  was  short  (Fig.  1).
agnetic  resonance
edullar  lesion  in  the  intersection  of  the  medial  third  and
he  distal  third  of  the  left  femur  that  was  associated  with
ultifragmentary  fracture  over  the  pathological  area  in  a
eoplastic  lesion,  without  being  able  to  rule  out  a  bone  cyst
r  another  pathological  process  diagnosis  (Fig.  2A  and  B).
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Figure  1  Anteroposterior  and  lateral  femur  X-rays  that  evi-
dence  cross-sectional  breaks  in  continuity  at  the  distal  third
of the  femur,  in  the  pathological  area,  due  to  the  presence
of a  radiolucent,  medullar,  expansive,  monostotic  lesion  of
70 mm  ×  45  mm.  There  is  periosteal  reaction  and  the  transition
Figure  3  Anteroposterior  X-ray  of  femur.  Data  related  to
osteotomies  with  osteosynthesis  in  left  femur  with  centromedu-
lar nail  and  three  antirotation  screws.
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A  trucut-type  biopsy  of  the  lesion  was  performed,  from
which  the  histopathological  diagnosis  corresponded  to  an
adamantinoma,  the  reason  why  a  R0  wide  local  excision
was  made  in  the  left  femoral  diaphysis  with  open  reduction
and  ﬁxation  of  the  pathological  fracture  in  the  left  femur
with  an  unreamed  femoral  nail  (UFN)  and  the  placement  of
cadaveric  bone  grafting.  Fig.  3  shows  the  ﬁnal  reconstruc-
tion  of  the  limb  with  an  anteroposterior  plate  in  the  left
thigh  where  data  related  to  osteotomies  can  be  observed;
there  is  osteosynthesis  in  the  left  femur  with  centromedular
nail  and  three  antirotation  screws.
c
N
Figure  2  Magnetic  resonance  of  the  femur.  Medullar  lesion  in  the  
femur that  was  associated  with  multifragmentary  fracture  over  path
out a  bone  cyst  or  another  disease  diagnosis.athological anatomy
he  medial  and  distal  third  of  the  femur  was  amputated.
here  was  a 6  cm  tumour  in  the  medial  section  at  the  long
xis,  with  ill-deﬁned  inﬁltrating  borders  (Fig.  4).  Histologi-
ally,  the  neoplasia  was  biphasic,  with  solid  areas,  of  which
ells  had  an  epithelioid  aspect  and  basaloid  pattern;  nuclei
ere  ovoid  and  comprised  of  ﬁnely  granular  chromatin;  the
ytoplasm  was  wide,  eosinophilic  and  clear  in  some  areas.
mmunostaining  demonstrated  expression  of  the  mixture  of
eratins  and  cytokeratins  5/6  (Fig.  5).  There  were  other
reas  of  osteoﬁbrous  aspect  and  nests  of  basaloid  cells
aught  between  them.  Therefore,  in  the  TNM  pathological
lassiﬁcation  for  bone  cancer,  this  tumour  is  classiﬁed  as  T1
0  M0  G1,  clinical  stage  IA.
intersection  of  the  medial  third  and  the  distal  third  of  the  left
ological  area  in  a  neoplastic  lesion  without  being  able  to  rule
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Figure  4  Pathological  anatomy.  Biphasic  lesion  with  solid
areas, of  which  cells  had  an  epithelioid  aspect  and  basaloid  pat-
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during  the  advanced  stage  they  affect  the  perilesional  soft
tissue  and  the  bone  marrow,  and  symptoms  such  as  pain  and
limb  deformity  increase.
Since  it  is  a  slow-growing  tumour,  metastases  are  not  that
frequent  and  they  are  present  in  20%  of  the  patients  at  the
time  of  diagnosis;  the  most  frequent  locations  are  the  lungs,
other  bones  and  the  lymphatic  system.10
Imaging  department
X-rays  show  an  osteolytic  image,  well  delimitated,  com-
prised  of  one  or  several  cysts,  which  can  extend
longitudinally  in  the  cortex  or  destroy  it,  spreading  to  the
bone  marrow.  There  can  be  a  periosteal  or  soft  tissue  reac-
tion.  There  can  also  be  a  multifocal  reaction  in  the  same
bone  or  in  other  bones.  Differential  diagnosis  with  ﬁbrous
dysplasia  and  osteoﬁbrous  dysplasia  is  important,  the  ﬁrst
being  common  in  younger  patients.10
Magnetic  resonance  shows  low  density  in  T1,  while  there
is  a high  level  of  capture  in  T2.12
From  a  histological  point  of  view,  adamantinoma  is  a
biphasic  tumour  with  epithelial  characteristics  and  osteoﬁ-
brous  components.12 It  is  classiﬁed  into  two  types:  Classic
adamantinoma  usually  appears  in  patients  over  the  age
of  20.  Histologically,  it  has  an  epithelial  and  osteoﬁbrous
component  and  is  a  more  aggressive  tumour.12 Differen-
tiated  adamantinoma  (juvenile  intracortical,  osteoﬁbrous
dysplasia-like).  This  appears  in  younger  patients.  Histologi-
cally,  it  appears  as  masses  of  epithelial  cells.  Its  evolution
is  more  benign.12
Neoplastic  cells  vary  from  small  to  large,  located  in  an
osteoﬁbrous  matrix  content.  There  are  several  histological
Table  1  2009  TNM  classiﬁcation.
TX  Primary  tumour
T0 No  evidence  of  primary  tumour
T1 Tumour  smaller  than  8  cm  at  itsern. Ovoid  nuclei;  ﬁnely  granular  chromatin;  the  cytoplasm  was
ide,  eosinophilic  and  clear.
iscussion
rimary  bone  malignant  tumours  are  infrequent  and  only
omprise  0.2%  of  all  primary  malignant  tumours  and  5%  of
alignant  paediatric  tumours.  The  predominance  of  primary
one  malignant  tumours  is  estimated  at  8  in  every  1,000,000
ersons,  with  2500  new  cases  diagnosed  per  year  in  the
nited  States.10 Adamantinoma  represents  <1%  of  all  bone
alignant  tumours.1 Clinical  presentation  of  these  tumours
ccurs  during  the  second  and  ﬁfth  decades  of  life,  aver-
ge  age  between  25  and  35  years.  They  rarely  occur  during
nfancy;  only  3%  of  the  cases  involve  children  under  the  age
f  10.11 There  is  a  male/female  ratio  of  5:4.9
There  is  a  predilection  for  long  bones:  in  80%  of  the  cases
hey  are  located  at  the  tibial  diaphysis,  and  with  less  fre-
uency  at  the  ﬁbula,  humerus  or  in  the  bones  of  hands
r  feet,  and  it  involves  the  tibia  and  the  ﬁbula  simulta-
eously  in  only  10%  of  the  cases.10,11 In  their  initial  stage  they
re  located  at  the  affected  bone’s  cortex  and  they  can  be
symptomatic  or  have  a  very  slight  symptomatology,  while
igure  5  Immunohistochemistry.  Expression  of  cytokeratin
/6.
widest  point
T2 Tumour  larger  than  8  cm  at  its  widest
point
T3 Discontinuous  tumour  in  the  primary
tumour  site
NX Regional  lymph  nodes  cannot  be
assessed
N0 Without  metastatic  regional  lymph
nodes
N1 With  metastatic  regional  lymph  nodes
M0 No  distant  metastases
M1 Distant  metastases
M1a  Lung  metastasis
M1b Other  metastases  location
GX Grade  cannot  be  assessed
G1  Well-differentiated  --  low  grade
G2 Moderately  differentiated  --  low
grade
G3 Poorly  differentiated
G4  Non-differentiated  (Ewing’s  sarcoma
is classiﬁed  as  G4)
G: histological grade; M: metastasis; N: ganglia; T: tumour.
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Table  2  Clinical  stages.
Clinical  stages  TNM  Grade
Stage  T  N  M
IA  T1  N0  M0  G1,  G2,  GX
IB T2  N0  M0  H1,  G2,  GX
T3 N0  M0  G1,  G2,  GX
IIA T1  N0  M0  G3/G4
IIB T2  N0  M0  G3/G4
III T3  N0  M0  G3
IVA Any T N0  M1a  Any  G
IVB Any  T N1  Any  M Any  G
Any T  Any  
G: histological grade; M: metastasis; N: ganglia; T: tumour.
variants13:  tubular,  basaloid,  ﬂaky,  fusiform  and  osteoﬁbrous
dysplasia-like.  Calciﬁcation  areas,  giant  cells  and  foamy  his-
tiocytes  are  frequent.  Epithelial  cells  express  cytokeratins,
particularly  cytokeratin  7,  5/6,  14,  17  and  19.
Since  bone  tumours  are  handled  differently  according
to  their  histology,  it  is  essential  to  do  a  biopsy,  which
must  always  be  performed  by  the  surgeon  who  will  be  in
charge  of  the  ﬁnal  treatment  of  the  disease.  Differential
diagnosis  is  mainly  performed  in  osteoﬁbrous  dysplasias,
which  occurs  in  patients  under  the  age  of  10.  It  is  a  dis-
ease  with  benign  characteristics  and  the  presentation  place
involves  both  the  tibia  and  the  ﬁbula.  It  can  regress  spon-
taneously  in  puberty  in  up  to  33%  of  the  cases.12 Other
differential  diagnoses  are:  ﬁbrous  dysplasias,  chondromyx-
oid  ﬁbromas,  chondrosarcomas,  osteomyelitis,  eosinophilic
granulomas,  giant-cell  tumours,  epithelial  metastases  and
angiosarcomas.12 Bone  tumours  are  classiﬁed  according  to
the  TNM  system  (Tables  1  and  2)  and  according  to  the  Ennek-
ing  system  (Table  3).
Treatment
These  are  slow-growing  tumours  and  if  they  have  ade-
quate  margins  their  potential  to  present  local  recurrences
or  metastases  is  limited.
The  marginal  resection  of  these  tumours  has  a local
recurrence  of  up  to  32%.
En-bloc  resection:  with  this  type  of  intervention  there
should  be  no  local  recurrences.  Amputation:  this  should  only
be  performed  in  cases  where  the  neurovascular  bundle  is
compromised,  if  there  is  vast  invasion  of  soft  tissues,  cuta-
neous  compromise  or  recurrences.12
Table  3  Enneking  system.
Stage  Grade  Location
IA  Low  Intracompartmental  T1
IB Low  Extracompartmental  T2
IIA High  Intracompartmental  T1
IIB High  Extracompartmental  T2
III Any  grade  with
regional  or  distant
metastases
Any  location
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Radiotherapy: Since  adamantinomas  are  low-grade
esions  with  an  extremely  low  mitotic  index,  they  are
adioresistant  lesions.
The  use  of  chemotherapy  for  this  disease  has  not  proven
o  be  effective.
rognosis
s  in  every  oncological  pathological  process,  the  progno-
is  will  depend  on  the  clinical  stage  in  which  the  patient  is
efore  treatment.  In  a  revision  by  Qureshi  et  al.14 in  which  a
umour-free  border  resection  was  performed  in  70  patients,
n  overall  survival  rate  of  87.2%  was  reported  after  10  years.
onclusion
damantinomas  are  infrequent  tumours  and  it  is  important
o  recognise  these  types  of  tumours  from  the  beginning,
ince  their  prognosis  is  excellent  during  early  stages.  It  is
mportant  to  always  do  a  biopsy  that  conﬁrms  the  diagno-
is  and  have  full  surgical  equipment  that  includes  a  surgical
ncologist  and  an  orthopaedic  surgeon  to  be  able  to  obtain
dequate  free  borders,  since  survival  is  very  high.  A proper
econstruction  that  ensures  adequate  mobility  and  function-
ng  of  the  affected  limb  is  required.
onﬂict of interest
he  authors  declare  that  there  are  no  conﬂicts  of  interest.
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